Dicerna Pharmaceuticals, Inc.
DRNA
DRNA was delisted on the 27th of December, 2021.
51 hedge funds and large institutions have $128M invested in Dicerna Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 17 closing their positions.
93% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 14
24% less funds holding
Funds holding: 67 → 51 (-16)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
40% less capital invested
Capital invested by funds: $216M → $128M (-$87.2M)
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$8.38M |
| 2 |
Morgan Stanley
New York
|
+$2.92M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$2.28M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.13M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$811K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$8.31M |
| 2 |
O
OrbiMed
New York
|
-$1.98M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.88M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.74M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.47M |
DRNA Hedge Fund Activity: Q3 2015 in Review
51 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q3 2015, worth a combined $128M — down 40% from $216M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of DRNA and 1 opened new positions — a net loss of 16 holders — while 14 trimmed existing stakes and 27 added.
The largest buyer was RTW Investments, adding an estimated $8.38M. The largest seller was Franklin Resources, exiting entirely with an estimated $8.31M sold.
- 51 institutional investors held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q3 2015, down from 67 in Q2 2015.
- Funds reported $128M of Dicerna Pharmaceuticals, Inc. stock for Q3 2015, down 40% quarter-over-quarter.
- 1 fund opened new Dicerna Pharmaceuticals, Inc. positions in Q3 2015 and 17 closed out, a net change of -16 holders.
- The largest Dicerna Pharmaceuticals, Inc. buyer in Q3 2015 was RTW Investments, an estimated $8.38M added.
- The largest Dicerna Pharmaceuticals, Inc. seller in Q3 2015 was Franklin Resources, an estimated $8.31M sold.
Based on aggregated 13F filings for Q3 2015.